# Expanded Access Protocol for an Intermediate Size Population - RAVICTI for Byler Disease

> **NCT02094222** · — · NO_LONGER_AVAILABLE · sponsor: **Robert Squires, Jr.**

## Conditions studied

- Byler Disease

## Interventions

- **DRUG:** RAVICTI

## Key facts

- **NCT ID:** NCT02094222
- **Lead sponsor:** Robert Squires, Jr.
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2019-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02094222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02094222, "Expanded Access Protocol for an Intermediate Size Population - RAVICTI for Byler Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02094222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*